Impact of first- and second-line treatment for Hodgkin’s lymphoma on the incidence of AML/MDS and NHL—experience of the German Hodgkin’s Lymphoma Study Group analyzed by a parametric model of carcinogenesis
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/22/3/681/19446175/mdq408.pdf
Reference49 articles.
1. Treatment of Hodgkin lymphoma: the past, present, and future;Evens;Nat Clin Pract Oncol,2008
2. Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease;Diehl;N Engl J Med,2003
3. Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's Lymphoma: 10 years of follow-up of the GHSG HD9 Study;Engert;J Clin Oncol,2009
4. Long-term toxicity of early stages of Hodgkin's disease therapy: the EORTC experience. EORTC Lymphoma Cooperative Group;Cosset;Ann Oncol,1991
5. Effect of ABVD chemotherapy with and without mantle or mediastinal irradiation on pulmonary function and symptoms in early-stage Hodgkin's disease;Hirsch;J Clin Oncol,1996
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Survivorship care for patients curatively treated for Hodgkin’s and non-Hodgkin’s lymphoma: a scoping review;Journal of Cancer Survivorship;2023-12-04
2. Acute Myeloid Leukemias After the Treatment of Classical Hodgkin’s Lymphoma: A Literature Review;Clinical oncohematology;2022
3. Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis;Cochrane Database of Systematic Reviews;2017-09-13
4. Hodgkin lymphoma: MOPP chemotherapy to PD-1 blockade and beyond;American Journal of Hematology;2015-11-26
5. Hodgkin lymphoma microenvironment: old and new therapeutic targets;Hodgkin And Non-Hodgkin Lymphomas Seen Through Their Microenvironment: Impact on Diagnosis, Prognosis and Innovative Therapy (Volume 2);2015-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3